ID YBAK_HAEIN Reviewed; 158 AA. AC P45202; Q9RP30; DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot. DT 21-FEB-2001, sequence version 2. DT 02-SEP-2026, entry version 148. DE RecName: Full=Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK; DE EC=4.2.-.-; GN Name=ybaK; OrderedLocusNames=HI_1434; OS Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd). OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Pasteurellales; Pasteurellaceae; Haemophilus. OX NCBI_TaxID=71421; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 51907 / DSM 11121 / KW20 / Rd; RX PubMed=7542800; DOI=10.1126/science.7542800; RA Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., RA Kerlavage A.R., Bult C.J., Tomb J.-F., Dougherty B.A., Merrick J.M., RA McKenney K., Sutton G.G., FitzHugh W., Fields C.A., Gocayne J.D., RA Scott J.D., Shirley R., Liu L.-I., Glodek A., Kelley J.M., Weidman J.F., RA Phillips C.A., Spriggs T., Hedblom E., Cotton M.D., Utterback T.R., RA Hanna M.C., Nguyen D.T., Saudek D.M., Brandon R.C., Fine L.D., RA Fritchman J.L., Fuhrmann J.L., Geoghagen N.S.M., Gnehm C.L., McDonald L.A., RA Small K.V., Fraser C.M., Smith H.O., Venter J.C.; RT "Whole-genome random sequencing and assembly of Haemophilus influenzae RT Rd."; RL Science 269:496-512(1995). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 51907 / DSM 11121 / KW20 / Rd; RA Bonander N., Eisenstein E.; RL Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases. RN [3] RP FUNCTION IN CYS-TRNA(PRO) EDITING, AND MUTAGENESIS OF LYS-46. RX PubMed=15322138; DOI=10.1074/jbc.c400304200; RA An S., Musier-Forsyth K.; RT "Trans-editing of Cys-tRNAPro by Haemophilus influenzae YbaK protein."; RL J. Biol. Chem. 279:42359-42362(2004). RN [4] RP FUNCTION AS A DEACYLASE, AND SUBSTRATE SPECIFICITY. RX PubMed=15886196; DOI=10.1074/jbc.m502174200; RA Ruan B., Soll D.; RT "The bacterial YbaK protein is a Cys-tRNAPro and Cys-tRNA Cys deacylase."; RL J. Biol. Chem. 280:25887-25891(2005). RN [5] RP SUBUNIT. RX PubMed=16087664; DOI=10.1074/jbc.m507550200; RA An S., Musier-Forsyth K.; RT "Cys-tRNA(Pro) editing by Haemophilus influenzae YbaK via a novel RT synthetase.YbaK.tRNA ternary complex."; RL J. Biol. Chem. 280:34465-34472(2005). RN [6] RP FUNCTION, REACTION MECHANISM, SUBSTRATE SPECIFICITY, AND MUTAGENESIS OF RP TYR-20; PHE-29; LYS-46; THR-47; GLY-101; SER-129; GLY-131; GLY-134 AND RP SER-136. RX PubMed=21768119; DOI=10.1074/jbc.m111.232611; RA So B.R., An S., Kumar S., Das M., Turner D.A., Hadad C.M., RA Musier-Forsyth K.; RT "Substrate-mediated fidelity mechanism ensures accurate decoding of proline RT codons."; RL J. Biol. Chem. 286:31810-31820(2011). RN [7] RP X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS). RX PubMed=10813833; RX DOI=10.1002/(sici)1097-0134(20000701)40:1<86::aid-prot100>3.0.co;2-y; RA Zhang H., Huang K., Li Z., Banerjei L., Fisher K.E., Grishin N.V., RA Eisenstein E., Herzberg O.; RT "Crystal structure of YbaK protein from Haemophilus influenzae (HI1434) at RT 1.8-A resolution: functional implications."; RL Proteins 40:86-97(2000). CC -!- FUNCTION: Functions in trans to edit the amino acid from incorrectly CC charged Cys-tRNA(Pro) via a Cys-tRNA(Pro) deacylase activity. Probably CC compensates for the lack of Cys-tRNA(Pro) editing by ProRS. Is also CC able to deacylate Cys-tRNA(Cys), and displays weak deacylase activity CC in vitro against Gly-tRNA(Gly), as well as, at higher concentrations, CC some other correctly charged tRNAs. Does not cleave Pro-tRNA(Pro). CC {ECO:0000269|PubMed:15322138, ECO:0000269|PubMed:15886196, CC ECO:0000269|PubMed:21768119}. CC -!- SUBUNIT: May form a tertiary complex with ProRS and tRNA(Pro), as it CC can be cross-linked to E.coli ProRS and to E.coli tRNA(Pro) in vitro. CC It cannot compete with Ef-Tu for aminoacyl-tRNA binding, suggesting it CC acts before release of the charged aminoacyl-tRNA from the synthetase. CC {ECO:0000269|PubMed:16087664}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. CC -!- MISCELLANEOUS: Reaction mechanism involves exclusion of catalytic water CC from the active site and substrate-mediated catalysis: the sulfhydryl CC side chain of the Cys substrate acts as a nucleophile and attacks the CC carbonyl center of the ester bond, leading to the cleavage of the Cys- CC tRNA ester bond and formation of a cyclic cysteine thiolactone CC intermediate. In contrast, the INS editing domain of ProRS catalyzes CC Ala-tRNA(Pro) hydrolysis via nucleophilic attack by a catalytic water CC molecule (PubMed:21768119). {ECO:0000305|PubMed:21768119}. CC -!- SIMILARITY: Belongs to the prolyl-tRNA editing family. YbaK/EbsC CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L42023; AAC23081.1; -; Genomic_DNA. DR EMBL; AF174386; AAD54290.1; -; Genomic_DNA. DR PIR; H64171; H64171. DR PDB; 1DBU; X-ray; 1.80 A; A=1-158. DR PDB; 1DBX; X-ray; 1.80 A; A/B=1-158. DR AlphaFoldDB; P45202; -. DR SMR; P45202; -. DR STRING; 71421.HI_1434; -. DR EnsemblBacteria; AAC23081; AAC23081; HI_1434. DR KEGG; hin:HI_1434; -. DR PATRIC; fig|71421.8.peg.1491; -. DR eggNOG; COG2606; Bacteria. DR HOGENOM; CLU_094875_1_1_6; -. DR OrthoDB; 9809296at2; -. DR PhylomeDB; P45202; -. DR BioCyc; HINF71421:G1GJ1-1457-MONOMER; -. DR EvolutionaryTrace; P45202; -. DR Proteomes; UP000000579; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0043906; F:Ala-tRNA(Pro) deacylase activity; IDA:UniProtKB. DR GO; GO:0002161; F:aminoacyl-tRNA deacylase activity; IBA:GO_Central. DR GO; GO:0106074; P:aminoacyl-tRNA metabolism involved in translational fidelity; IBA:GO_Central. DR CDD; cd00002; YbaK_deacylase; 1. DR FunFam; 3.90.960.10:FF:000002; Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase; 1. DR Gene3D; 3.90.960.10; YbaK/aminoacyl-tRNA synthetase-associated domain; 1. DR InterPro; IPR004369; Prolyl-tRNA_editing_YbaK/EbsC. DR InterPro; IPR036754; YbaK/aa-tRNA-synt-asso_dom_sf. DR InterPro; IPR007214; YbaK/aa-tRNA-synth-assoc-dom. DR NCBIfam; TIGR00011; YbaK_EbsC; 1. DR PANTHER; PTHR30411:SF0; CYS-TRNA(PRO)_CYS-TRNA(CYS) DEACYLASE YBAK; 1. DR PANTHER; PTHR30411; CYTOPLASMIC PROTEIN; 1. DR Pfam; PF04073; tRNA_edit; 1. DR PIRSF; PIRSF006181; EbsC_YbaK; 1. DR SUPFAM; SSF55826; YbaK/ProRS associated domain; 1. DR PDBsum; 1DBU; -. DR PDBsum; 1DBX; -. PE 1: Evidence at protein level; KW 3D-structure; Cytoplasm; Lyase; Protein biosynthesis; Reference proteome. FT CHAIN 1..158 FT /note="Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK" FT /id="PRO_0000168623" FT SITE 29 FT /note="Participates in proton transfer during catalysis" FT /evidence="ECO:0000250" FT MUTAGEN 20 FT /note="Y->A: 45-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT MUTAGEN 29 FT /note="F->A: 29-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT MUTAGEN 46 FT /note="K->A: 66-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:15322138, FT ECO:0000269|PubMed:21768119" FT MUTAGEN 46 FT /note="K->I: 38-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:15322138, FT ECO:0000269|PubMed:21768119" FT MUTAGEN 46 FT /note="K->R: 44-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:15322138, FT ECO:0000269|PubMed:21768119" FT MUTAGEN 47 FT /note="T->A: 21-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT MUTAGEN 101 FT /note="G->A: 36-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT MUTAGEN 129 FT /note="S->A: 5.6-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT MUTAGEN 131 FT /note="G->A: 28-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT MUTAGEN 134 FT /note="G->A: 7.4-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT MUTAGEN 136 FT /note="S->A: 3.6-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT MUTAGEN 136 FT /note="S->H: 16-fold decrease in Cys-tRNA(Pro) deacylation FT activity." FT /evidence="ECO:0000269|PubMed:21768119" FT CONFLICT 117 FT /note="N -> K (in Ref. 1; AAC23081)" FT /evidence="ECO:0000305" FT HELIX 3..11 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 16..19 FT /evidence="ECO:0007829|PDB:1DBU" FT HELIX 32..37 FT /evidence="ECO:0007829|PDB:1DBU" FT HELIX 41..43 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 44..52 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 58..65 FT /evidence="ECO:0007829|PDB:1DBU" FT HELIX 72..79 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 84..86 FT /evidence="ECO:0007829|PDB:1DBU" FT HELIX 89..96 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 105..107 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 114..117 FT /evidence="ECO:0007829|PDB:1DBU" FT HELIX 118..122 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 126..129 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 135..139 FT /evidence="ECO:0007829|PDB:1DBU" FT HELIX 141..148 FT /evidence="ECO:0007829|PDB:1DBU" FT STRAND 151..153 FT /evidence="ECO:0007829|PDB:1DBU" SQ SEQUENCE 158 AA; 17155 MW; 45723E9DFC99535A CRC64; MTPAIDLLKK QKIPFILHTY DHDPNNQHFG DEAAEKLGID PNRSFKTLLV AENGDQKKLA CFVLATANML NLKKAAKSIG VKKVEMADKD AAQKSTGYLV GGISPLGQKK RVKTVINSTA LEFETIYVSG GKRGLSVEIA PQDLAKVLGA EFTDIVDE //